title: Imiquimod for the treatment of skin cancer.
abstract: Imiquimod is a topically applied immunomodulator. Although initially approved for genital and perianal warts, dermatologists have prescribed this compound for many neoplastic and nonneoplastic skin conditions. The US Food and Drug Administration recently approved imiquimod for the treatment of actinic keratoses. This article reviews the literature on imiquimod in the treatment of cutaneous malignancies.
authors.affiliation: Department of Dermatology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 697, Rochester, NY 14642, USA.
authors.forename: Carrine A
authors.initials: CA
authors.lastname: Burns
authors.forename: Marc D
authors.initials: MD
authors.lastname: Brown
mesh_terms: D000279:Administration, Cutaneous; D000634:Aminoquinolines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D006801:Humans; D000077271:Imiquimod; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod